Figure 4.

Cut-and-paste approach for removal and replacement of cMyBP-C N-terminal domains in cardiomyocytes from homozygous Spy-C mice. (A) Gene-edited Spy-C mice express modified cMyBP-C with a TEVp recognition site (light blue rectangle) and a SpyTag (orange rectangle) inserted between domains C7 and C8. Inset: Immunofluorescence localization of cMyBP-C in homozygous (HO) and WT Spy-C myocytes showing expected localization (green) in each half sarcomere. Z-lines are shown stained with α-actinin (red). (B) Cut and paste of cMyBP-C in Triton X-100–permeabilized cardiomyocytes from HO Spy-C mice. (B 1) Cut: TEVp treatment releases genetically encoded (γ) C0–C7 domains, which are soluble and can be removed from sarcomeres through gentle rinsing. Inset: Immunofluorescence showing loss of cMyBP-C stripes after TEVp treatment in HO myocytes but not WT myocytes. (B 2) Paste: New recombinant rC0C7-sc domains (green; encoding any desired modification such as mutations, deletions, and fluorescent probes) are added to the bath where they become covalently attached to st-C8C10 on the thick filament via a spontaneous bond formed between SpyCatcher and SpyTag. Inset: Immunofluorescence localization showing reappearance of cMyBP-C stripes (green) after addition of rC0C7-sc in HO myocytes but not rC0C7 lacking encoded SpyCatcher in HO myocytes. Data and figure modified from Napierski et al. (2020). Figure created with BioRender.com.

or Create an Account

Close Modal
Close Modal